DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$234.38
+1.86%Margins
Gross margin
58.6%
EBITDA margin
27.7%
EBIT margin
20.4%
Net margin
16.9%
FCF margin
22.4%
8.1%
Return on equity
4.6%
Return on assets
6.5%
Return on invested capital
0.28x
Asset turnover
$6.9B
Cash from operations
$8.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026